Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 2, 2012, Pages 322-331

  Ishola, Ismail O ^a,b   Chatterjee, Manavi ^b   Tota, Santoshkumar ^b   Tadigopulla, Narender ^b   Adeyemi, Olufunmilayo O ^a   Palit, Gautam ^b   Shukla, Rakesh ^b  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Amentoflavone; Anxiety; Depression; Elevated plus maze; Flumazenil; Forced swimming test; Metergoline

Indexed keywords

AMENTOFLAVONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATROPINE; CNESTIS FERRUGINEA EXTRACT; CYPROHEPTADINE; FLUMAZENIL; METERGOLINE; PLANT EXTRACT; PRAZOSIN; SULPIRIDE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CNESTIS FERRUGINEA; CONNARACEAE; CONTROLLED STUDY; DRUG SCREENING; ELEVATED PLUS MAZE; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMOBILIZATION; LIGHT DARK TEST; MALE; MAZE TEST; MOUSE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; TAIL SUSPENSION TEST; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BIFLAVONOIDS; CONNARACEAE; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; PLANT EXTRACTS; ROTAROD PERFORMANCE TEST;

CONNARACEAE; MUS;

EID: 84866482215     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.08.017     Document Type: Article

References (70)

1. 2 receptor expression and dopamine release in the nucleus accumbens of the rat Psychopharmacology (Berl) 140 1998 470 477
2. O. Arias-Carrion, and E. Pǒppel Dopamine, learning, and reward-seeking behavior Acta Neurobiol Exp (Wars) 67 2007 481 488
3. S.A. Back, B.H. Han, N.L. Luo, C.A. Chricton, K.L. Arvin, and D.M. Holtzman Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia J Neurosci 22 2002 455 463
4. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
5. K.H. Baureithel, K.B. Buter, A. Engesser, W. Burkard, and W. Schaffner Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum Pharm Acta Helv 72 1997 153 157
6. 1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests Eur Neuropsychopharmacol 17 2007 172 179
7. H.M. Burkhill 2nd edition The useful plants of west tropical Africa vol.1 1985 White Friars Press UK
8. V. Butterweck, A. Nahrstedt, J. Evans, S. Hufeisen, L. Rauser, and J. Savage In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs Psychopharmacology (Berl) 162 2002 193 202
9. K. Clement, C.R. Covertson, M.J. Johnson, and K. Dearing St. John's wort and the treatment of mild to moderate depression: a systematic review Holist Nurs Pract 20 2006 197 203
10. G. Dagyte, J.A. Den Boer, and A. Trentani The cholinergic system and depression Behav Brain Res 221 2011 574 582
11. W. Danysz, W. Kostowski, W. Kozak, and M. Hauptmann On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression Pol J Pharmacol Pharm 38 1986 285 298
12. G.R. Dawson, and M.D. Tricklebank Use of the elevated plus maze in the search for novel anxiolytic agents Trends Pharmacol Sci 16 1995 33 36
13. M.J. Detke, M. Rickels, and I. Lucki Active behaviours in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology 121 1995 66 72
14. L. Du, D. Bakish, Y.D. Lapierre, A.V. Ravindran, and P.D. Hrdina Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder Am J Med Genet 96 2000 56 60
15. M.W. Dunham, and T.S. Miya A note on a simple apparatus for detecting neurological deficit in rat and mice J Am Pharm Assoc Sci 46 1957 208 209
16. B.W. Dunlop, and C.B. Nemeroff The role of dopamine in the pathophysiology of depression Arch Gen Psychiatry 64 2007 327 337
17. M.J. Durcan, and R.G. Lister Does directed exploration influence locomotor activity in a hole-board test? Behav Neural Biol 51 1989 121 125
18. 3 receptor antagonism Pharmacol Biochem Behav 68 2001 677 683
19. A.S. Elhwuegi Central monoamines and their role in major depression Prog Neuropsychopharmacol Biol Psychiatry 28 2004 435 451
20. F. Ferrari, and D. Giuliani Effects of (-) eticlopride and 7-OH-DPAT on the tail-suspension test in mice J Psychopharmacol 11 1997 339 344
21. S. File, R. Lister, and D. Nutt The ansiogenic action of benzodiazepine antagonists Neuropharmacology 21 1982 1033 1037
22. 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination J Neurochem 62 1994 2262 2268
23. L. Gu, Y. Liu, Y. Wang, and L. Yi Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrina J Ethnopharmacol 139 2012 780 787
24. H. Gutmann, R. Bruggisser, W. Schaffner, K. Bogman, A. Botomino, and J. Drewe Transport of amentoflavone across the blood-brain barrier in vitro Planta Med 68 2002 804 807
25. M.B. Hamner, and B.I. Diamond Plasma dopamine and norepinephrine correlations with psychomotor retardation, anxiety, and depression in non-psychotic depressed patients: a pilot study Psychiatry Res 64 1996 209 211
26. S.L. Handley, and L. Singh Chronic antidepressant treatment reduces central beta-adrenoceptor sensitivity in a behavioural test Eur J Pharmacol 127 1986 97 103
27. A receptors Bioorg Med Chem Lett 13 2003 2281 2284
28. D.R. Helton, J.E. Berger, J.F. Czachura, K. Rasmussen, and M.J. Kallman Central nervous system characterization of the newcholecystokinin B antagonist LY288513 Pharmacol Biochem Behav 53 1996 493 502
29. J. Hutchinson, and J.M. Dalziel Flora of West Tropical Africa, London 1958 743
30. I.O. Ishola, and R.B. Ashorobi Anti-stress potential of aqueous root extract of Cnestis ferruginea Int J Pharmacol 3 3 2007 295 298
31. I.O. Ishola, A.J. Akindele, and O.O. Adeyemi Analgesic and anti-inflammatory activities of Cnestis ferruginea Vahl ex DC (Connaraceae) root methanolic extract J Ethnopharmacol 135 2011 55 62
32. I.O. Ishola, O.E. Agbaje, T. Narender, O.O. Adeyemi, and R. Shukla Bioactivity guided isolation of analgesic and anti-inflammatory constituents of Cnestis ferruginea Vahl ex DC (Connaraceae) root J Ethnopharmacol 142 2012 383 389
33. D.S. Janowsky, M.K. el-Yousef, J.M. Davis, and H.J. Sekerke A cholinergic adrenergic hypothesis of mania and depression Lancet 2 1972 632 635
34. H.K. Kim, K.H. Son, H.W. Chang, S.S. Kang, and H.P. Kim Amentoflavone, a plant biflavone: a new potential anti-inflammatory agent Arch Pharm Res 21 1998 406 410
35. V. Klimek, J.E. Schenck, H. Han, C.A. Stockmeier, and G.A. Ordway Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study Biol Psychiatry 52 2002 740 748
36. G. Lambert, M. Johansson, H. Agren, and P. Friberg Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders Arch Gen Psychiatry 57 2000 787 793
37. N. Liebenberg, G. Wegener, B.H. Harvey, and C.B. Brink Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism Behav Brain Res 209 2010 137 141
38. K. Linde, C.D. Mulrow, and M. Egger St. John's Wort for depression Cochrane Database Syst Rev 2005 CD000448
39. H.R. Maribel, G.B. Yolanda, M. Sergio, D.V. Gabriela, S.B.V. Glauce, and T. Jaime Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans J Ethnopharmacol 107 2006 53 58
40. 13C NMR studies on some naturally occurring amentoflavone and hinokiflavone biflavonoids Phytochemistry 26 1987 3335 3337
41. A.J. Mayorga, A. Dalvi, M.E. Page, S. Zimov-Levinson, R. Hen, and I. Lucki Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice J Pharmacol Exp Ther 298 2001 1101 1107
42. A. McLean, J.S. Rubinsztein, T.W. Robbins, and B.J. Sahakian The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression Psychopharmacology (Berl) 171 2004 286 297
43. S.F. McTavish, P.J. Cowen, and T. Sharp Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release Psychopharmacology (Berl) 141 1999 182 188
44. 2 receptors during depression and self-harm Am J Psychiatry 160 2003 90 99
45. 1A receptor in the mouse tail suspension test Neuropsychopharmacology 29 2004 461 469
46. E.G. Moreira, N. Nascimento, J.R. Rogero, and V.S. Vassilieff Gabaergic benzodiazepine system is involved in the crotoxin-induced anxiogenic effect Pharmacol Biochem Behav 65 2000 7 13
47. P.C. Moser An evaluation of the elevated plus maze test using the novel anxiolytic buspirone Psychopharmacology 99 1989 48 53
48. M. Nielsen, S. Frokjaer, and C. Braestrup High affinity of the naturally-occurring biflavonoid, amentoflavone, to brain benzodiazepine receptors in vitro Biochem Pharmacol 37 1988 3285 3287
49. A. Nikiforuk, K. Gołembiowska, and P. Popik Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats Eur Neuropsychopharmacol 20 2010 37 48
50. E. Nogueira, and V.S. Vassilieff Hypnotic, anticonvulsant and muscle relaxant effects of Rubus brasiliensis. Involvement of GABAA-system J Ethnopharmacol 70 2000 275 280
51. S.C. Pandey, X. Ren, J. Sagen, and G.N. Pandey Beta-adrenergic receptor subtypes in stress-induced behavioral depression Pharmacol Biochem Behav 51 1995 339 344
52. G.I. Papakostas Dopaminergic-based pharmacotherapies for depression Eur Neuropsychopharmacol 16 2006 391 402
53. S. Pellow, P. Chopin, M. Briley, and S.E. File The validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 1985 149 167
54. A receptors are involved in magnesium induced anxiolytic-like behaviour in mice Pharmacol Rep 60 2008 483 489
55. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336
56. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair in rats and mice: strain differences and the effects of imipramine Eur J Pharmacol 51 1978 291 294
57. 3 receptors in the activity of antidepressants in the mouse forced swimming test Eur J Pharmacol 325 1997 129 135
58. 1A/1B antagonists and 8-OH-DPAT in the mouse forced swimming test Eur Neuropsychopharmacol 8 1998 169 173
59. A.C. Scates, and P.M. Doraiswamy Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression Ann Pharmacother 34 2000 1302 1312
60. N.L. Schramm, M.P. McDonald, and L.E. Limbird The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety J Neurosci 21 2001 4875 4882
61. D.H. Shin, Y.C. Bae, J.S. Kim-Han, J.H. Lee, L.Y. Choi, and K.H. Son Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic-ischemic brain damage via multiple mechanisms J Neurochem 96 2006 561 572
62. K. Stachowicz, E. Chojnacka-Wójcik, K. Kłak, and A. Pilc Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent Neuropharmacology 52 2 2007 306 312
63. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology 85 1985 367 370
64. E.A. Stone, and D. Quartermain Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression Biol Psychiatry 46 1999 1287 1300
65. D. Treit Animal models for the study of anti-anxiety agents: a review Neurosci Biobehav Rev 9 1984 203 222
66. G. Ulak, O. Muttu, P. Tanyen, F.I. Komosuoghi, F.Y. Akar, and B.F. Erden Involvement of serotonin receptor subtypes in the antidepressant - like effect of trim in the rat forced swimming test Pharmacol Biochem Behav 95 2010 308 314
67. 2C receptors and their atypical regulation properties Life Sci 72 2003 2429 2449
68. C. Wolfman, H. Viola, A. Paladini, F. Dajas, and J.H. Medina Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea Pharmacol Biochem Behav 47 1994 1 4
69. R. Young, and D.N. Johnson A fully automated light/dark apparatus useful for comparing anxiolytic agents Pharmacol Biochem Behav 40 1991 739 743
70. Z. Zhang Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders Life Sci 75 2004 1659 1699